HeyBryan Media Announces Management and Director Changes

HeyBryan Media Inc. (CSE: HEY) (OTCQB: HEYBF) (FSE: 9HB) ("HeyBryan" or the "Company") is pleased to announce changes to management. On November 9, 2020 Lance Montgomery resigned as President and Chief Executive Officer and as a Director of the Company. Under Lance's management, the Company was unsuccessful in developing the Company's business sufficiently to attract financing. Lance has been replaced by the appointment of William White as Chief Executive Officer and President. The Company is pleased to announce the departure of directors Rita Theil, Liane Hathaway and Michael Stulp, who resigned after being unsuccessful in finding a suitable merger candidate. Daniel Kang and Angelo Rajasooria have been appointed to the Company's Board of Directors to fill two of the vacancies.

Newly appointed director Daniel Kang, a resident of California, USA, has 8 years of experience as a professional in banking and compliance. He worked at Tricor Group from July 2012 to December 2016 where he helped American and European companies navigate through the corporate compliance and tax requirements of the Japanese system. At Tricor, he worked with clients from a wide range of industries, with notable clients including Uber, Mercedes Benz, BBC News and Tommy Bahama. Mr. Kang is a co-founder of Ocean Green Management, a California LLC focused on applying for Type 10 retail licenses across the State of California, where he worked from December 2016 to January 2020. Mr. Kang has a Bachelor of Arts from Haverford College and has completed the General Course at the London School of Economics.

Newly appointed director Angelo Rajasooria, a resident of Port Coquitlam, British Columbia, has a background and education in entrepreneurship and research. From 2016 - 2019 he was a co-founder and Director of Neil and Sons, handling distribution for Voortman Cookies to the grocery chain market in the Greater Vancouver area. His experience also includes working for three years as a Research Scientist in charge of organizing and analyzing data for clinical trials at the Downtown HIV Clinic and the BC Center for Children's and Women's Health. Mr. Rajasooria graduated from UBC with a Bachelors of Science in Cell Biology and Genetics.

William White, a resident of West Vancouver, British Columbia, is the newly appointed President and Chief Executive Officer of the Company. He has been a shareholder of the Company since prior to its initial public offering over one year ago and he currently holds 926,000 shares in the Company. Since 2018 Mr. White has been the CEO and President of Komo Plant-Based Foods Inc., a private company. He is also the founder of several junior gold exploration companies, and is the President and CEO of Lynx Gold Corp. which was recently acquired. From February 2017 - March 2018, Mr. White worked in his family's home renovation business. From 2007 to 2017, William worked in safety and logistics compliance and in human resources management in the long haul transport industry. His experience in the transport industry included recruitment and managing all U.S. Department of Transportation and Canadian National Safety Code ratings inclusive of accident investigations, implementing, monitoring, and managing safety programs, policies, and procedures. He has been an active investor in the capital markets for the past five years and has taken courses in Financing, Governance and Compliance for Public Companies at Simon Fraser University.

The Company is also pleased to announce the resignation of Blair Jordan from his part-time position as Chief Financial Officer. The Company is currently reviewing candidates to fill the role.

The current board of directors and management of the Company consists of Spiros Margaris, who has been an independent director of the Company since 2018, and newly appointed directors Daniel Kang and Angelo Rajasooria, and President and CEO, William White. Both newly appointed directors are independent, as that term is defined in National Instrument 52-110.

The Company is confident that the new board and management team will be more resourceful than the prior management team in developing value for the shareholders. As an initial task the Company's new management will look closely at the Company's existing debt and recent securities issuances, and will also examine recent operations and opportunities presented to the Company.

Investor Relations Contact:
William White, President & CEO
778-229-4781

The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.

Cautionary Statement Regarding Forward-Looking Statements

This press release includes forward-looking information and statements (collectively, "forward-looking statements") under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, intellectual property protection, and sale of, and demand for, the HeyBryan App and the services offered thereby, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and risks related to the extent of the impact of the COVID-19 pandemic, including the duration, spread, severity, and any recurrence of the COVID-19 pandemic, the duration and scope of related government orders and restrictions, the impact on our employees, and the extent of the impact of the COVID-19 pandemic on capital markets and our ability to obtain financing. The Company cautions readers not to place undue reliance on forward-looking statements provided by the Company, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/67892

News Provided by Newsfile via QuoteMedia

The Conversation (0)
Linius Technologies Limited

Linius Now Live with First Deployment in American Football

Linius Technologies Limited (ASX:LNU) (Linius or Company) – the only cloud-based solution that unlocks the value of video archives with immersive, deeply personalized viewer experiences via its Linius Media Solutions portfolio – is pleased to announce that the deployment of its sports solution, Whizzard, is now live with its customer Lone Star Conference.

Keep reading...Show less
Sona's Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study

Sona's Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that a detailed biomarker analysis of the recently reported pre-clinical melanoma study conducted at Dalhousie University (the "Study") indicates that, beyond shrinking tumors on its own, Sona's Targeted Hyperthermia Therapy ("THT") also stimulates the innate immune system to target and eliminate untreated (contralateral) tumors when combined with a standard immunotherapeutic drug, IL-2. (See figure #1, below.) On the basis of efficacy data achieved in two different murine cancer models (triple negative breast cancer and malignant melanoma), the Company is now proceeding with safety and biocompatibility testing that will be required by regulating agencies to enter into human studies.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
E-Power Resources Inc. Announces Commencement of the 2024 Tetepisca Exploration Program

E-Power Resources Inc. Announces Commencement of the 2024 Tetepisca Exploration Program

Commencement of the Tetepisca Exploration Program for 2024

E-Power Resources Inc. (CSE: EPR) ("E-Power" or the "Company") announces that it has mobilized its exploration crew to the Tetepisca Graphite Project and the 2024 exploration program is underway.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
PRINCIPAL TECHNOLOGIES ANNOUNCES CLOSING OF FIRST TRANCHE OF PRIVATE PLACEMENT

PRINCIPAL TECHNOLOGIES ANNOUNCES CLOSING OF FIRST TRANCHE OF PRIVATE PLACEMENT

Principal Technologies Inc. (the " Company ") (TSXV: PTEC) (FSE: J07), is pleased to announce the closing of the first tranche (" Tranche 1 ") of its previously announced non-brokered private placement (the " Offering ") with one investor, MRPT Invest UG (" MRPT "), a company owned and controlled by Markus Mair . The Company issued a total of 4,000,000 units at $0.25 per unit for gross proceeds of $1,000,000 . Each unit (a " Unit ") will consist of one common share (a ' Share ") of the Company and one common share purchase warrant (a " Warrant "). Each Warrant entitles the holder to purchase one additional Share of the Company at $0.30 for a period of two (2) years from the date of closing. The Warrants are subject to a blocker term that prohibits exercise of the Warrants to the extent the holder would as a result of any exercise exceed 19.99% of then issued Shares.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Sona's Therapy Shows Significant Preclinical Efficacy in Second Cancer

Sona's Therapy Shows Significant Preclinical Efficacy in Second Cancer

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that its targeted hyperthermia therapy ("THT") demonstrated positive results in a second preclinical cancer model. Findings just presented at the 2024 STING & TLR Targeted Therapies Summit for immunotherapies in San Diego, California, show that Sona's THT achieved responses in a preclinical melanoma model equal to that which was recently reported from its triple negative breast cancer study. THT effectively treated melanoma tumors in all animals when administered on its own. Further, when THT was combined with doses of interleukin-2 ("IL-2"), a standard immunotherapy, a synergistic effect was shown whereby greater treatment response, measured by tumor volume reduction, was achieved in comparison to either approach alone.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Apple The Exchange TRX to welcome its first customers this Saturday, June 22, in Kuala Lumpur

Apple The Exchange TRX to welcome its first customers this Saturday, June 22, in Kuala Lumpur

Apple's first retail location in Malaysia will offer its full lineup of products and services, unparalleled support from over 160 team members, and sessions with local creatives

Apple® today previewed Apple The Exchange TRX, the first Apple Store® in Malaysia. Located in the heart of Kuala Lumpur's new Tun Razak Exchange (TRX) central business district, the new store will deliver the magic of Apple in the country like never before. Customers can discover and buy Apple's innovative lineup of products and services, receive exceptional service from knowledgeable team members, and learn how to get the most out of their devices through free Today at Apple® sessions.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×